Despite extensive efforts, the validation of prognostic tissue markers in prostate cancer has not yet resulted in the widespread implementation of novel diagnostic tests.
van Leenders
Geert
G
Department of Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands. g.vanleenders@erasmusmc.nl
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000235:genetics; D014408:Biomarkers, Tumor / Q000235:genetics*; D015342:DNA Probes; D018628:Gene Dosage; D016259:Genes, myc / Q000235:genetics*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000235:genetics
D014408:Biomarkers, Tumor; D015342:DNA Probes